Hodgson Ian 4

What Happened

• Ian Hodgson, Chief Operating Officer of Corbus Pharmaceuticals (CRBP), sold 847 shares on 2026-02-17 in an open-market/private sale. The weighted average price was $7.38 per share (range $7.37–$7.42), generating approximately $6,253 in proceeds. According to the filing, the sale was to cover tax withholding tied to RSU vesting and was not a discretionary sale (F1, F2).

Key Details

• Transaction date: 2026-02-17; Filing date: 2026-02-18 (filed timely).
• Shares sold: 847; weighted avg price: $7.38; price range: $7.37–$7.42; proceeds ≈ $6,253 (F2).
• Reason: Sell-to-cover to satisfy tax withholding obligations on vested RSUs (mandated by issuer), not a voluntary disposition by the insider (F1).
• Shares owned after transaction: Not specified in the information provided on this filing.
• Other holdings: Filing notes there are 46,362 unvested RSUs subject to vesting schedules as previously reported (F3).

Context

• This was a routine sell-to-cover tied to RSU settlement and tax obligations, which is common and generally not considered a signal of reduced confidence by the insider. Purchases tend to be more informative about insider sentiment; this transaction was administrative in nature.